Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-16-033604
Filing Date
2016-11-15
Accepted
2016-11-15 19:20:38
Documents
2
Period of Report
2016-08-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1642
2 EX-24 DOCUMENT attachment1.htm EX-24 3590
  Complete submission text file 0000899243-16-033604.txt   6676
Mailing Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121
Business Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Issuer) CIK: 0000850261 (see all company filings)

EIN.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 8767 E. VIA DE VENTURA, SUITE 190 SCOTTSDALE AZ 85258
Business Address
ZELDIS JEROME B (Reporting) CIK: 0001433982 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36150 | Film No.: 162001072